`Paper No.
`Date filed: June 20, 2016
`
`Filed On Behalf Of:
`
`Alkermes Pharma Ireland Limited and
`
`Alkermes Controlled Therapeutics, Inc.
`
`By:
`
`Scott K. Reed
`
`sreed@fchs.com
`212-218-2100
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`LUYE PHARMA GROUP LTD., LUYE PHARMA(USA) LTD., SHANDONG
`LUYE PHARMACEUTICAL CO., LTD., and NANJING LUYE
`
`PHARMACEUTICAL CO., LTD.,
`
`Petitioners,
`
`V.
`
`ALKERJVIES PHARMA IRELAND LTD,
`
`Patent Owner.
`
`Case IPR2016-01095
`
`Patent 6,667,061
`
`
`
`Patent Owners Alkermes Pharma Ireland Limited and Alkermes
`
`Controlled Therapeutics, Inc. (hereinafter, collectively “Alkermes” or “Patent
`
`Owners”) hereby appoint Scott K. Reed (Reg. No. 32,433) and Justin J. Oliver
`
`(Reg. No. 44,986) as their attorneys to prosecute the aforementioned proceeding
`
`and to transact all business in the United Patent and Trademark Office connected
`
`therewith.
`
`Please address all correspondence as follows:
`
`Scott K. Reed
`
`Fitzpatrick, Cella, Harper & Scinto
`1290 Avenue of the Americas
`
`New York, NY 10104-3 800
`Telephone: (212) 218-2100
`Facsimile: (212) 218-2200
`sreed@fchs.com
`
`Dated: June 17, 2016
`Derpclz June 17, 2016
`Claire M. Vasios, Ph.D.
`Shane Cooke
`Vice President, Intellectual Property
`President
`Alkerrnes Pharma Ireland Limited Alkermes Controlled Therapeutics, Inc.
`Connaught House
`852 Winter Street
`1 Burlington Road
`Waltham, MA 02451
`Dublin 4, Ireland D04 C5 Y6
`
`
`
`8
`Paper No.
`Date filed: June 20, 2016
`
`Filed On Behalf Of:
`
`Alkermes Pharma Ireland Limited and
`
`Alkermes Controlled Therapeutics, Inc.
`
`By:
`
`Scott K. Reed
`
`sreed@fchs.com
`212-218-2100
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`LUYE PHARMA GROUP LTD., LUYE PHARMA(USA) LTD., SHANDONG
`LUYE PHARMACEUTICAL CO., LTD., and NANJING LUYE
`PHARMACEUTICAL CO., LTD.,
`
`Petitioners,
`
`V.
`
`ALKERMES PHARMA IRELAND LTD,
`
`Patent Owner.
`
`Case IPR2016-01095
`
`Patent 6,667,061
`
`
`
`Patent Owners Alkermes Pharma Ireland Limited and Alkermes
`
`Controlled Therapeutics, Inc. (hereinafter, collectively “Alkermes” or “Patent
`
`Owners”) hereby appoint Scott K. Reed (Reg. No. 32,433) and Justin J. Oliver
`
`(Reg. No. 44,986) as their attorneys to prosecute the aforementioned proceeding
`
`and to transact all business in the United Patent and Trademark Office connected
`
`therewith.
`
`Please address all correspondence as follows:
`
`Scott K. Reed
`
`Fitzpatrick, Celia, Harper & Scinto
`1290 Avenue of the Americas
`
`New York, NY 10104-3800
`Telephone: (212) 218-2100
`Facsimile: (212)218-2200
`sreed@,fchs.com
`
`Dated: June 17, 2016
`
`Dated: June 17, 2016
`
`/ "
`
`Is’
`
`3
`
`r
`
`)
`
`(E818./,/Ll’ U 5/
`
`
`Claire M. Vasios, »h.D.
`Shane Cooke
`Vice President, Intellectual Property
`President
`Alkermes Pharma Ireland Limited Alkermes Controlled Therapeutics, Inc.
`Connaught House
`852 Winter Street
`1 Burlington Road
`Waltham, MA 02451
`Dublin 4, Ireland D04 C5 Y6